Procalcitonin as biomarker of antibiotic effectivity in communityacquired pneumonia

• Main Authors: Ana Khusnul Faizah, -, Winariani, -, Yulistiani, -, Samirah, -
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Universitas Airlangga 2015
• Subjects: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• Online Access: https://repository.unair.ac.id/124105/4/Bukti%20C-16%20Artikel.pdf; https://repository.unair.ac.id/124105/2/Bukti%20C-16%20Kualitas%20Karil.pdf; https://repository.unair.ac.id/124105/3/Bukti%20C-16%20Turnitin.pdf; https://repository.unair.ac.id/124105/; https://journal.unair.ac.id/FMI@procalcitonin-as-biomarker-of-antibiotic-effectivity-in-communityacquired-pneumonia-article-9476-media-3-category-3.html
• Institution: Universitas Airlangga

Major therapy for community-acquired pneumonia (CAP) is antibiotics. Procalcitonin used as the measure of antibioticseffectiveness. Procalcitonin is specific biomarker that elevates in acute bacterial infection. This study aimed to analyze procalcitoninas effective antibiotics biomarker in CAP patie...